ArticleCancer medicine2021

The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation-positive relapsed/refractory acute myeloid leukemia.

Jessica K Altman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.